Levetir

Levetir
100 mg/mL, 5 mL vial
Registration Number 衛署藥製字第057956號
Levetir
Indications

The following epilepsy patients who are temporarily unsuitable or unable to be treated with oral anti-epileptic drugs: Individual treatment of localized epileptic seizures (with or without secondary generalized seizures) in patients over 16 years old. Partial epileptic seizures (with or without secondary generalized seizures) in children and adults over four years old, myotonic seizures in adolescents and adult patients over twelve years old, and adolescent and adult patients over sixteen years old and Adjuvant treatment of primary generalized tonic-clonic seizures in adults with constitutional generalized epilepsy.

product details
NameLevetir
Registration Number衛署藥製字第057956號
Generic NameLevetiracetam
TerritoryTaiwan
Package100 mg/mL, 5 mL vial
IndicationThe following epilepsy patients who are temporarily unsuitable or unable to be treated with oral anti-epileptic drugs: Individual treatment of localized epileptic seizures (with or without secondary generalized seizures) in patients over 16 years old. Partial epileptic seizures (with or without secondary generalized seizures) in children and adults over four years old, myotonic seizures in adolescents and adult patients over twelve years old, and adolescent and adult patients over sixteen years old and Adjuvant treatment of primary generalized tonic-clonic seizures in adults with constitutional generalized epilepsy.
StorageBelow 25℃
Adverse Reaction Contact

24 hour phone: +886-800-035-511

email : pharmacovigilance@ubi-pharma.com